Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients: cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
Objectives: The leukocyte-derived myeloperoxidase (MPO), the nitric oxidase synthase (NOS) inhibitor asymmetrical dimethyl-arginine (ADMA) and the renin-angiotensin-aldosterone-system (RAAS) are associated with cardiovascular diseases (CVD). This study aimed to investigate potential interactions bet...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
18 March 2017
|
| In: |
Clinical biochemistry
Year: 2017, Jahrgang: 50, Heft: 13/14, Pages: 739-745 |
| ISSN: | 1873-2933 |
| DOI: | 10.1016/j.clinbiochem.2017.03.013 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.clinbiochem.2017.03.013 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0009912016306841 
|
| Verfasserangaben: | Sieglinde Zelzer, Dietmar Enko, Stefan Pilz, Andreas Tomaschitz, Winfried März, Andreas Meinitzer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1577923030 | ||
| 003 | DE-627 | ||
| 005 | 20230426230741.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180725s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clinbiochem.2017.03.013 |2 doi | |
| 035 | |a (DE-627)1577923030 | ||
| 035 | |a (DE-576)507923030 | ||
| 035 | |a (DE-599)BSZ507923030 | ||
| 035 | |a (OCoLC)1341014476 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Zelzer, Sieglinde |e VerfasserIn |0 (DE-588)1163345490 |0 (DE-627)1027635938 |0 (DE-576)507927672 |4 aut | |
| 245 | 1 | 0 | |a Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients |b cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study |c Sieglinde Zelzer, Dietmar Enko, Stefan Pilz, Andreas Tomaschitz, Winfried März, Andreas Meinitzer |
| 264 | 1 | |c 18 March 2017 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Available online 18 March 2017 | ||
| 500 | |a Gesehen am 25.07.2018 | ||
| 520 | |a Objectives: The leukocyte-derived myeloperoxidase (MPO), the nitric oxidase synthase (NOS) inhibitor asymmetrical dimethyl-arginine (ADMA) and the renin-angiotensin-aldosterone-system (RAAS) are associated with cardiovascular diseases (CVD). This study aimed to investigate potential interactions between the RAAS, ADMA and MPO in cardiovascular risk patients. Design and methods. All in all, 1446 patients, who were referred to coronary angiography, were included in this prospective study. MPO, ADMA and circulating serum markers of the RAAS system were measured. Additionally, all-cause and CVD mortality, cardiovascular risk factors, inflammatory and endothelial markers, and medication use were investigated. Results: MPO concentrations were significantly associated with ADMA (P=0.002), renin (P=0.001) and angiotensin II levels (P=0.015), whereas ADMA was in tendency associated with renin (P=0.059) and significantly with angiotensin II (P=0.001). Both, ADMA and MPO were inversely correlated with angiotensinogen, angiotensin I and the angiotensin I/angiotensin II ratio. ADMA and angiotensin II were found stronger independent risk factors for all-cause and CVD mortality compared to MPO. Conclusions: MPO concentrations were significantly associated with higher ADMA levels and an up-regulated circulating RAAS in patients with CVD. Moreover, serum levels of ADMA and angiotensin II were shown to be more predictive for all-cause and CVD mortality compared to MPO. | ||
| 650 | 4 | |a Asymmetric dimethyl-arginine | |
| 650 | 4 | |a Cardiovascular disease | |
| 650 | 4 | |a Myeloperoxidase | |
| 650 | 4 | |a Renin-angiotensin-aldosterone-system | |
| 700 | 1 | |a März, Winfried |d 1958- |e VerfasserIn |0 (DE-588)1027603599 |0 (DE-627)729463605 |0 (DE-576)373454635 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical biochemistry |d Amsterdam [u.a.] : Elsevier Science, 1967 |g 50(2017), 13/14, Seite 739-745 |h Online-Ressource |w (DE-627)306354764 |w (DE-600)1496880-0 |w (DE-576)094107882 |x 1873-2933 |7 nnas |a Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study |
| 773 | 1 | 8 | |g volume:50 |g year:2017 |g number:13/14 |g pages:739-745 |g extent:7 |a Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clinbiochem.2017.03.013 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0009912016306841 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180725 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1027603599 |a März, Winfried |m 1027603599:März, Winfried |d 60000 |d 61400 |e 60000PM1027603599 |e 61400PM1027603599 |k 0/60000/ |k 1/60000/61400/ |p 5 | ||
| 999 | |a KXP-PPN1577923030 |e 3019484359 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"18 March 2017","dateIssuedKey":"2017"}],"name":{"displayForm":["Sieglinde Zelzer, Dietmar Enko, Stefan Pilz, Andreas Tomaschitz, Winfried März, Andreas Meinitzer"]},"recId":"1577923030","note":["Available online 18 March 2017","Gesehen am 25.07.2018"],"physDesc":[{"extent":"7 S."}],"id":{"doi":["10.1016/j.clinbiochem.2017.03.013"],"eki":["1577923030"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients","subtitle":"cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study","title_sort":"Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients"}],"relHost":[{"origin":[{"publisher":"Elsevier Science","dateIssuedDisp":"1967-","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1967"}],"recId":"306354764","pubHistory":["1.1967/68 -"],"part":{"year":"2017","extent":"7","volume":"50","text":"50(2017), 13/14, Seite 739-745","pages":"739-745","issue":"13/14"},"id":{"issn":["1873-2933"],"zdb":["1496880-0"],"eki":["306354764"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"display":"Canadian Society of Clinical Chemists","role":"isb"}],"disp":"Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) studyClinical biochemistry","note":["Gesehen am 04.02.20"],"title":[{"subtitle":"official journal of the Canadian Society of Clinical Chemists","title":"Clinical biochemistry","title_sort":"Clinical biochemistry"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"]}],"language":["eng"],"person":[{"given":"Sieglinde","family":"Zelzer","role":"aut","display":"Zelzer, Sieglinde"},{"display":"März, Winfried","role":"aut","family":"März","given":"Winfried"}]} | ||
| SRT | |a ZELZERSIEGMYELOPEROX1820 | ||